WithSecure Oyj
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
WithSecure Corporation, Stock Exchange Release, 31 May 2025 at 9:45 EEST
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
WithSecure announced on 23 January 2025 its intention to divest the cyber security consulting business to Neqst, Swedish investment company.
On 31 May 2025, the parties completed the transaction in accordance with the sale and purchase agreement. EUR 13.5 million, corresponding to 60 % of the agreed enterprise value of EUR 22.5 million, deducted by the transferring net assets of the business, is paid in cash by the buyer. The remaining 40 % is variable purchase price, based on the performance of the business in 2025 and 2026, and it becomes payable in two installments in the beginning of 2026 and 2027.
All closing conditions of the transaction have been fulfilled.
With the transaction, approximately 230 employees located in Finland, UK, Sweden, Denmark, Singapore, Italy, and US will transfer to the buyer.
“I wish our former colleagues and their new company the best of luck in the future. As for WithSecure, the consulting divestment allows us to fully focus on our Elements strategy of becoming the flagship of European cybersecurity”, states Antti Koskela, President and CEO of WithSecure.
Contact information:
Laura Viita
VP, Controlling, investor relations and sustainability
WithSecure Corporation
+358 50 487 1044
investor-relations@withsecure.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG1.6.2025 15:00:00 CEST | Press release
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
Gatorade31.5.2025 17:39:49 CEST | Press release
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
F. Hoffmann-La Roche Ltd31.5.2025 14:05:00 CEST | Press release
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
Ipsen Pharma31.5.2025 14:00:00 CEST | Press release
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
Teva Pharmaceutical Industries Ltd31.5.2025 03:05:00 CEST | Press release
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom